Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,125 | -7,825 | -5,035 | -2,716 | -1,970 |
| Depreciation Amortization | 1 | 4 | 3 | 2 | 1 |
| Other Working Capital | -27 | -122 | -147 | -156 | -144 |
| Other Operating Activity | 595 | 1,744 | 1,149 | 390 | 165 |
| Operating Cash Flow | $-1,557 | $-6,200 | $-4,030 | $-2,480 | $-1,948 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | N/A | -7,536 | -7,536 | -7,536 | -5,514 |
| Financing Cash Flow | $N/A | $-7,536 | $-7,536 | $-7,536 | $-5,514 |
| Beginning Cash Position | 13,468 | 27,204 | 27,204 | 27,204 | 27,204 |
| End Cash Position | 11,911 | 13,468 | 15,638 | 17,188 | 19,743 |
| Net Cash Flow | $-1,557 | $-13,736 | $-11,566 | $-10,016 | $-7,461 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,557 | -6,200 | -4,030 | -2,480 | -1,948 |
| Free Cash Flow | -1,557 | -6,200 | -4,030 | -2,480 | -1,948 |